Refusing – Refusing.org
Releasing a new product? Just launched a company? Then you need to learn how to write press releases. A press release will get your business featured on huge publications with hungry customers eagerly waiting to buy from you. But, this is easier than done. Writing a press release that will get picked up by news outlets and explode brand awareness[1]...
READ MORE How to Write a Press Release That Editors Can’t Refuse
Dive Brief: Sixty-nine percent of workers either strongly support or somewhat support a right of first refusal arrangement, according to a YouGov Blue survey commissioned by the Democracy Collaborative. Last week, the Democracy Collaborative, a progressive research group, released a report outlining a model for “right of first refusal” (sometimes called “right to own”), which could give workers the opportunity to purchase...
READ MORE ‘Right of first refusal’ has wide worker support, report claims
VANCOUVER, Feb. 6, 2019 /CNW/ – Sirona Biochem Corp[1]. (TSX-V: SBM) (FSE: ZSB) (the “Company“) announces that it has signed a Right of First Refusal (ROFR) agreement with an industry-leading, skincare company to license Sirona’s skin lightener, TFC-1067. The company is a leader in North American skincare sales with rapidly growing international sales channels. The skincare company has completed extensive due...
ARDSLEY, N.Y.–(BUSINESS WIRE[1])–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for INBRIJA. INBRIJA is an investigational treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen. Upon its preliminary review, FDA determined that...
